Table 1. Sample and patient characteristics in the German HIV-1 Seroconverter Study Cohort (1996–2017).
| N (%) | |
|---|---|
| Genotyped samples | 2715 (100) |
| Gender | |
| Male | 2577 (94.9) |
| Female | 129 (4.8) |
| Unknown | 9 (0.3) |
| Median age at seroconversion | 33 years |
| Transmission | |
| MSM | 2404 (88.6) |
| HET | 210 (7.7) |
| IDU | 31 (1.1) |
| High prevalence country | 16 (0.6) |
| Exposure at work | 7 (0.3) |
| Blood products | 1 (0.04) |
| Unknown | 46 (1.7) |
| Seroconversion status | |
| Acute | 1095 (40.3) |
| Documented | 1620 (59.7) |
| Time between last negative and first positive test | |
| <12M | 859 (53.0) |
| 12M-18M | 322 (19.9) |
| 18M-24M | 212 (13.1) |
| 24M-36M | 227 (14.0) |
| HIV-1 subtype | |
| B | 2392 (88.1) |
| Non-B | 323 (11.9) |
| TDR | |
| Sensitive | 2249 (82.8) |
| Resistant | 466 (17.2) |
| TDR against | |
| One drug class | 425 (91.2) |
| Two drug classes | 35 (7.5) |
| Three drug classes | 6 (1.3) |
N: Number; M: Months; MSM: Men who have sex with men; HET: Heterosexual contact; IDU: Intravenous drug users